Letter

Decline in mortality in children with HIV in the UK and Ireland

BMJ 2004; 328 doi: 10.1136/bmj.328.7438.524-a (Published 26 February 2004)
Cite this as: BMJ 2004;328:524.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Authors' reply

  1. D M Gibb, reader in epidemiology (mbh@ctu.mrc.ac.uk),
  2. T Duong, statistician,
  3. P A Tookey, senior lecturer in paediatric epidemiology
  1. Medical Research Council Clinical Trials Unit, London NW1 2DA
  2. Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, London WC1N 1EH

    EDITOR—Mhlongo and Maduna and Prime et al challenge the results of our study and think that we overlooked alternative reasons for the rapid fivefold decline in mortality, progression to AIDS, and hospital admission rates we reported in the CHIPS cohort of vertically HIV infected children in the United Kingdom and Ireland. We cannot agree that they provide viable alternative explanations for the dramatic reduction.

    Firstly, we did not include details of management of opportunistic infections, and we agree that there is indirect evidence that cotrimoxazole prophylaxis reduces the frequency of these (particularly Pneumocystis carinii pneumonia in infancy, as previously reported in the United Kingdom1 …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular